EP0642527 - AMPHIPHILIC NUCLEOSIDE PHOSPHATE ANALOGS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 15.11.1996 Database last updated on 07.06.2024 | Most recent event Tooltip | 04.01.2003 | Lapse of the patent in a contracting state New state(s): NL | published on 19.02.2003 [2003/08] | Applicant(s) | For all designated states SCHOTT, Herbert Hartmeyerstrasse 14 D-72076 Tübingen / DE | [1995/11] | Inventor(s) | 01 /
SCHWENDENER, Albert, Reto Mythenstrasse 1 CH-8802 Kilchberg / CH | 02 /
GUERIN, Frédérique 39, avenue René-Coty F-75014 Paris / FR | 03 /
Schott, Herbert Prof. Dr. Hartmeyerstrasse 14 D-72016 Tübingen / DE | [1995/11] | Representative(s) | Kinzebach, Werner, et al Reitstötter, Kinzebach & Partner Patentanwälte Postfach 86 06 49 81633 München / DE | [N/P] |
Former [1995/11] | Kinzebach, Werner, Dr., et al Patentanwälte Reitstötter, Kinzebach und Partner Postfach 86 06 49 D-81633 München / DE | Application number, filing date | 93905240.3 | 12.02.1993 | [1995/11] | WO1993EP00346 | Priority number, date | DE19924204211 | 13.02.1992 Original published format: DE 4204211 | DE19924224878 | 28.07.1992 Original published format: DE 4224878 | [1995/11] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO9316093 | Date: | 19.08.1993 | Language: | DE | [1993/20] | Type: | A1 Application with search report | No.: | EP0642527 | Date: | 15.03.1995 | Language: | DE | The application published by WIPO in one of the EPO official languages on 19.08.1993 takes the place of the publication of the European patent application. | [1995/11] | Type: | B1 Patent specification | No.: | EP0642527 | Date: | 10.01.1996 | Language: | DE | [1996/02] | Search report(s) | International search report - published on: | EP | 19.08.1993 | Classification | IPC: | C07H19/10, A61K31/70 | [1995/11] | CPC: |
C07H19/06 (EP,US);
C07H19/10 (EP,US)
| Designated contracting states | AT, CH, DE, DK, ES, FR, GB, IT, LI, NL, SE [1995/11] | Title | German: | AMPHIPHILE NUCLEOSIDPHOSPHATANALOGA | [1995/11] | English: | AMPHIPHILIC NUCLEOSIDE PHOSPHATE ANALOGS | [1995/11] | French: | ANALOGUES DE PHOSPHATES NUCLEOSIDES AMPHIPHILES | [1995/11] | Entry into regional phase | 11.08.1994 | National basic fee paid | 11.08.1994 | Designation fee(s) paid | 11.08.1994 | Examination fee paid | Examination procedure | 10.09.1993 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 11.08.1994 | Examination requested [1995/11] | 26.04.1995 | Despatch of communication of intention to grant (Approval: Yes) | 26.06.1995 | Communication of intention to grant the patent | 05.10.1995 | Fee for grant paid | 05.10.1995 | Fee for publishing/printing paid | Opposition(s) | 11.10.1996 | No opposition filed within time limit [1997/01] | Fees paid | Renewal fee | 27.02.1995 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | DK | 10.01.1996 | ES | 10.01.1996 | NL | 10.01.1996 | SE | 10.04.1996 | [2003/08] |
Former [2002/26] | DK | 10.01.1996 | |
ES | 10.01.1996 | ||
SE | 10.04.1996 | ||
Former [1998/15] | DK | 10.01.1996 | |
SE | 10.04.1996 | ||
Former [1996/38] | SE | 10.04.1996 | Cited in | International search | [Y]WO9006319 (SCHERING CORP [US]); | [Y]EP0392791 (WALKER RICHARD THOMAS [GB], et al) | [A] - JOURNAL OF MEDICINAL CHEMISTRY Bd. 31, 1988, WASHINGTON US Seiten 2040 - 2048 P.HERDEWIJN ET AL. 'Synthesis and Anti-HIV Activity of Different Sugar-Modified Pyrimidine and Purine Nucleosides.' | [A] - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA. Bd. 83, Nr. 21, November 1986, WASHINGTON US Seiten 8333 - 8337 P.A.FURMAN ET AL. 'Phosphorylation of 3'-Azido-3'-Deoxythymidine and Selective Interaction of the 5'-Triphosphate with Human Immunodeficiency Virus Reverse Transcriptase.' in der Anmeldung erwähnt |